Author: claimsbot

1. A handheld diabetes manager communicating with an external insulin pump and having a personal data module comprising:
a port configured to receive a test strip for blood glucose measurement;
a blood glucose measurement module cooperatively operable with a test strip inserted in the port for blood glucose measurement;
a communications module that selectively communicates via a wireless data link with an external insulin pump; and
a user interface module in data communication with the blood glucose measurement module and the communications module and operable to provide a graphical user interface on a display of the diabetes manager, wherein the graphical user interface includes a personal data menu screen from which a logbook option can be selected to display a logbook screen, the logbook screen displaying a plurality of time data records, each time data record including blood glucose data, bolus insulin data and carbohydrate data for a corresponding time, and a bolus icon and a first icon in association with the bolus icon when a bolus advice recommendation is accepted, and a second icon, different from the first icon, when a bolus advice recommendation is not accepted.
2. The handheld diabetes manager of claim 1, wherein the logbook screen displays a health event icon when a health event was entered during the corresponding time data record.
3. The handheld diabetes manager of claim 1, wherein the logbook screen displays a \u201cpump paused\u201d icon when the insulin pump was paused in the corresponding time data record.
4. The handheld diabetes manager of claim 1, wherein the logbook screen displays a blood glucose indicator icon associated with the blood glucose value of the corresponding time data record.
5. The handheld diabetes manager of claim 1, wherein the logbook screen displays a carb icon and the first icon in association with the carb icon when a carb advice recommendation is accepted, and the second icon when a carb advice recommendation is not accepted.
6. The handheld diabetes manager of claim 1, wherein the logbook screen displays different icons for each of standard, extended and multiwave bolus associated with each time data record.
7. The handheld diabetes manager of claim 1, wherein a detailed blood glucose screen reached for a time data record associated with an accepted bolus advice recommendation displays a lock icon indicating that the corresponding data cannot be changed.
8. A handheld diabetes manager communicating with an external insulin pump and having a personal data module comprising:
a port configured to receive a test strip for blood glucose measurement;
a blood glucose measurement module cooperatively operable with a test strip inserted in the port for blood glucose measurement;
a communications module that selectively communicates via a wireless data link with an external insulin pump; and
a user interface module in data communication with the blood glucose measurement module and the communications module and operable to provide a graphical user interface on a display of the diabetes manager, wherein the graphical user interface includes a personal data menu screen from which a trend graph option can be selected to display a trend graph screen, the trend graph screen displaying within a graph area a blood glucose line graph, a carb bar graph, a basal rate line graph and a bolus bar graph representing corresponding data during a selected time interval.
9. The handheld diabetes manager of claim 8, wherein the blood glucose line graph is a piecewise linear graph connecting data points corresponding to blood glucose data.
10. The handheld diabetes manager of claim 8, wherein the carb bar graph is a bar graph corresponding to carb data.
11. The handheld diabetes manager of claim 8, wherein the trend graph screen displays a color-coded area indicating a normal blood glucose range.
12. The handheld diabetes manager of claim 8, wherein the trend graph screen displays a color-coded line indicating a hypoglycemia limit.
13. The handheld diabetes manager of claim 8, wherein the trend graph screen displays along an upper portion of the graph area from left to right icons representing events that occurred in the trend graph’s time interval, including icons indicating health events, icons indicating \u201cpump stopped\u201d events and icons indicating \u201cpump paused\u201d events.
14. The handheld diabetes manager of claim 8, wherein the trend graph screen includes an \u201cicon help\u201d button for displaying a screen including a plurality of icons and their corresponding descriptions as used in the trend graph screen.
15. The handheld diabetes manager of claim 8, wherein the trend graph screen includes a left scroll arrow, a right scroll arrow and a report information field in between.
16. The handheld diabetes manager of claim 15, wherein the left and right scroll arrows operate to update the graph data with respective older or newer data at respective decrements and increments of time corresponding to a time scale for the selected time interval.
17. The handheld diabetes manager of claim 15, wherein a mealtime icon is displayed in the report information field, the mealtime icon representing a type of mealtime event selected for the graph, including before meal, after meal, bedtime, fasting, or all mealtime events.
18. The handheld diabetes manager of claim 8, wherein the trend graph screen includes a configure button for selecting time scale options, data option and mealtime options for graphical representation.
19. A handheld diabetes manager communicating with an external insulin pump and having a personal data module comprising:
a port configured to receive a test strip for blood glucose measurement;
a blood glucose measurement module cooperatively operable with a test strip inserted in the port for blood glucose measurement;
a communications module that selectively communicates via a wireless data link with an external insulin pump; and
a user interface module in data communication with the blood glucose measurement module and the communications module and operable to provide a graphical user interface on a display of the diabetes manager, wherein the graphical user interface includes a personal data menu screen from which a logbook option can be selected to display a logbook screen, and a trend graph option can be selected to display a trend graph screen, wherein:
the logbook screen displays a plurality of time data records, each time data record including blood glucose data, bolus insulin data and carbohydrate data for a corresponding time, a bolus icon and a first icon in association with the bolus icon when a bolus advice recommendation is accepted, and a second icon, different from the first icon, when a bolus advice recommendation is not accepted; and
the trend graph screen displays within a graph area a blood glucose line graph, a carb bar graph, a basal rate line graph and a bolus bar graph representing corresponding data during a selected time interval.
20. The handheld diabetes manager of claim 19, wherein a detailed blood glucose screen reached for a time data record associated with an accepted bolus advice recommendation displays a lock icon indicating that the corresponding data cannot be changed.
21. The handheld diabetes manager of claim 20, wherein the detailed blood glucose screen includes a bolus button and an icon displaying the type of bolus associated with the time data record.
22. The handheld diabetes manager of claim 21, wherein the detailed blood glucose screen displays a pump-paused icon combined with the bolus icon if the pump was paused during bolus delivery.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

What is claimed is:

1. An acoustic biosensor for implantation in a body, comprising:
a sensor element for measuring a physiological condition and for generating a signal representative of the physiological condition, and
a transducer element for energizing the sensor element, the transducer comprising
a cell member having a cavity,
a piezoelectric layer attached to the cell member, the piezoelectric layer having an external surface and an internal surface, the piezoelectric layer configured so as to enable fluctuations thereof at its resonance frequency upon impinging of an external acoustic wave,
a first electrode attached to the external surface, and
a second electrode attached to the internal surface, the first and second electrodes configured to generate electrical current from vibrations of the transducer element caused by an acoustic signal.
2. The biosensor of claim 1, wherein the cavity is etched into a substrate.
3. The biosensor of claim 2, wherein the substrate includes a plurality of cell members.
4. The biosensor of claim 1, wherein at least one of the first and second electrodes is specifically shaped so as to provide a maximal electrical output.
5. An acoustic biosensor for implantation in a body, comprising:
a sensor element for measuring a physiological condition and for generating a sensor signal representative of the physiological condition; and
a transducer element coupled to the sensor element for transmitting a signal out of the body, the transducer element comprising
a cell member having a cavity,
a flexible piezoelectric layer attached to the cell member, the piezoelectric layer having an external surface and an internal surface, the piezoelectric layer featuring such dimensions so as to enable fluctuations thereof at its resonance frequency upon impinging of an external acoustic wave,
a first electrode attached to the external surface, and
a second electrode attached to the internal surface, the first and second electrodes being electrically connected to an electrical circuit including a switching element for controllably changing the mechanical impedance of the piezoelectric layer in accordance with an electrical message signal.
6. An acoustic biosensor for monitoring a physiological condition at an implantation site in a body, comprising:
a sensing element for measuring a physiological condition at the implantation site and for generating an information signal representative of the physiological condition; and
a transducer element for converting an acoustic interrogation signal into energy for operating the sensor and for modulating the interrogation signal to transmit the information signal.
7. An acoustic biosensor for monitoring a physiological condition at an implantation site in a body, comprising:
a sensing element for measuring a physiological condition at the implantation site and for generating an information signal representative of the physiological condition; and
a transducer element for modulating an acoustic interrogation signal to transmit the information signal.
8. The biosensor of claim 7, further comprising a battery for operating the sensing element.
9. A method for monitoring a physiological condition at an implantation site in a body using an acoustic biosensor located at the implantation site, the biosensor comprising
a sensing element for measuring a physiological condition at the implantation site and for generating an information signal representative of the physiological condition, and
a transducer element for converting an acoustic interrogation signal into energy for operating the sensor and for modulating the interrogation signal to transmit the information signal, the method comprising:
providing an acoustic interrogation wave for impinging on the transducer element of the biosensor and thereby provide power to the sensing element, the acoustic wave having a reflected portion; and
modulating the reflected portion of the interrogation wave based on the information signal.
10. The method of claim 9, wherein modulation of the reflected portion of the interrogation wave is accomplished by controlling mechanical impedance of the transducer element.
11. The method of claim 9, wherein the implantation site is an aneurysmal sac.
12. The method of claim 9, wherein the implantation site is an abdominal aortic aneurysm.
13. A method for monitoring a physiological condition at an implantation site in a body using an acoustic biosensor located at the implantation site, the biosensor comprising
a sensing element for measuring a physiological condition at the implantation site and for generating an information signal representative of the physiological condition, and
a transducer element for modulating the interrogation signal to transmit the information signal, the method comprising:
providing an acoustic interrogation wave for impinging on the transducer element of the biosensor, the acoustic wave having a reflected portion; and
modulating the reflected portion of the interrogation wave based on the information signal.
14. The method of claim 13, wherein modulation of the reflected portion of the interrogation wave is accomplished by controlling mechanical impedance of the transducer element.
15. The method of claim 9, wherein the implantation site is an aneurysmal sac.
16. The method of claim 9, wherein the implantation site is an abdominal aortic aneurysm.

1. A dual sterilization containment vessel for biologically derived medical components comprising:
a hollow element having a wall, a proximal end, a distal end, and a lumen therebetween, said lumen configured and adapted to contain a biologically derived medical component and at least a portion of an apparatus configured and adapted to implant the biologically derived medical component in a living body;
a distal end cap;
a proximal end cap; and
a radiopaque sleeve,
wherein the proximal end cap has a secondary proximal end cap and ferrule sized and adapted to and capable of reversibly sealing the proximal end cap to a delivery catheter passing therethrough,
further wherein the combination of the hollow element, the distal end cap, the proximal end cap, the secondary proximal end cap, the ferrule, and the delivery catheter form a fluid tight system providing a continuous fluid connection between the interior of the hollow element and the lumen of the delivery catheter.
2. The dual sterilization containment vessel of claim 1, where in the hollow element, the distal cap, and the proximal cap comprise a material substantially unreactive with at least one biocide.
3. The dual sterilization containment vessel of claim 1, wherein the hollow element, the distal cap, and the proximal cap comprise a material which is substantially unchanged chemically and mechanically upon absorption of at least 4 gray of ionizing radiation.
4. The dual sterilization containment vessel of claim 1, wherein the hollow element, the distal cap, and the proximal cap comprise a material which is substantially unchanged chemically and mechanically upon absorption of at least 30 gray of ionizing radiation.
5. The dual sterilization containment vessel of claim 1, wherein the hollow element, the distal cap, and the proximal cap comprise a material which is substantially unchanged chemically and mechanically upon absorption of at least 40 gray of ionizing radiation.
6. The dual sterilization containment vessel of claim 1, wherein the hollow element, the distal cap, and the proximal cap comprise a material which is substantially unchanged chemically and mechanically upon absorption of at least 50 gray of ionizing radiation.
7. The dual sterilization containment vessel of claim 1, wherein the hollow element, the distal cap, and the proximal cap comprise a material which is substantially unchanged chemically and mechanically upon absorption of at least 4 gray of ionizing radiation when filled with the biocide of claim 2.
8. The dual sterilization containment vessel of claim 1, wherein the hollow element, the distal cap, and the proximal cap comprise a material which is substantially unchanged chemically and mechanically upon absorption of at least 30 gray of ionizing radiation when filled with the biocide of claim 2.
9. The dual sterilization containment vessel of claim 1, wherein the hollow element, the distal cap, and the proximal cap comprise a material which is substantially unchanged chemically and mechanically upon absorption of at least 40 gray of ionizing radiation when filled with the biocide of claim 2.
10. The dual sterilization containment vessel of claim 1, wherein the hollow element, the distal cap, and the proximal cap comprise a material which is substantially unchanged chemically and mechanically upon absorption of at least 50 gray of ionizing radiation when filled with the biocide of claim 2.
11. The dual sterilization containment vessel of claim 5, wherein the biologically derived medical component receives at least 4 gray of ionizing radiation when the hollow element absorbs 30 gray of ionizing radiation.
12. The dual sterilization containment vessel of claim 5, wherein the biologically derived medical component receives at least 4 gray of ionizing radiation when the hollow element absorbs 40 gray of ionizing radiation.
13. The dual sterilization containment vessel of claim 5, wherein the biologically derived medical component receives at least 4 gray of ionizing radiation when the hollow element absorbs 50 gray of ionizing radiation.
14. The dual sterilization containment vessel of claim 11, wherein the biologically derived medical component is treated bovine tissue.
15. The dual sterilization containment vessel of claim 14, wherein the biologically derived medical component is a replacement valve.
16. The dual sterilization containment vessel of claim 15, wherein the replacement valve is a replacement heart valve.
17. The dual sterilization containment vessel of claim 11, wherein the biologically derived medical component is treated porcine tissue.
18. The dual sterilization containment vessel of claim 17, wherein the biologically derived medical component is a replacement valve.
19. The dual sterilization containment vessel of claim 18, wherein the replacement valve is a replacement heart valve.
20. The dual sterilization containment vessel of claim 1, wherein at least a portion of at least one of the hollow element, the distal cap, and the proximal cap includes a region transparent to visible light.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A three dimensional multilayer integrated circuit comprising:
a first device layer with single crystal fabrication regions; and
a second device layer with single crystal fabrication regions, wherein said single crystal fabrication regions of said second device layer are formed while said second layer is on top of said first layer, with minimal detrimental heat transfer to said first device layer utilizing a controlled laser layer crystallization process for re-crystallization, wherein a crystallization area is defined to prevent undesired heat transfer between sad first device layer and said second device layer and said crystallization area is included in a single crystal fabrication region of said second device layer formed from silicon seed of said first device layer.
2. A three dimensional multilayer integrated circuit of claim 1 wherein said single crystal fabrication regions of said second device layer are formed from silicon seed of said first device layer.
3. A three dimensional multilayer integrated circuit of claim 1 wherein said single crystal fabrication regions of said second layer are defined by silicon isolation trenches.
4. A three dimensional multilayer integrated circuit of claim 1 wherein said single crystal fabrication regions are the size of a transistor.
5. A three dimensional multilayer integrated circuit of claim 1 wherein said first layer comprises peripheral devices and said second layer comprises core devices.
6. A three dimensional multilayer integrated circuit of claim 1 wherein said first layer and said second layer comprise similar circuitry arrays.
7. A three dimensional multilayer integrated circuit of claim 1 wherein said first layer is utilized in association with a first application and said second layer is utilized in association with a second application.